Inventor · disambiguated record
Weilan Ye
Also filed as: YE WEILAN
16 granted patents·23 pending applications·137 citations·filing 1998–2018
92Inventor score
Top patents by PatentIndex Score
39 records- 0194US8350010B2Anti-alpha5/beta1 antibodyGENENTECH INC·Filed 2011·Granted Jan 8, 2013·25 cites·22 claims
- 0292US7973138B2AntibodiesGENENTECH INC·Filed 2008·Granted Jul 5, 2011·16 cites·14 claims
- 0389US9522954B2Anti-LRP5 antibodies and methods of useGENENTECH INC·Filed 2015·Granted Dec 20, 2016·3 cites·31 claims
- 0488US8404811B2Humanized anti-EGFL7 antibodies and methods using sameYE WEILAN·Filed 2010·Granted Mar 26, 2013·6 cites·23 claims
- 0587US8962275B2Anti-α5β1 antibodies and uses thereofLIANG WEI-CHING·Filed 2011·Granted Feb 24, 2015·9 cites·9 claims
- 0683US6277820B1Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cellsGENENTECH INC·Filed 1998·Granted Aug 21, 2001·67 cites·3 claims
- 0779US8398976B2Antibodies to EGFL7 and methods for their useYE WEILAN·Filed 2011·Granted Mar 19, 2013·4 cites·57 claims
- 0875US8574576B2Humanized anti-EGFL7 antibodies and methods using sameGENENTECH INC·Filed 2012·Granted Nov 5, 2013·1 cites·30 claims
- 0975US8124740B2Anti- α5 β1 antibodies and uses thereofLIANG WEI-CHING·Filed 2010·Granted Feb 28, 2012·2 cites·5 claims
- 1074US7135334B2PRO20044 nucleic acidsGENENTECH INC·Filed 2002·Granted Nov 14, 2006·3 cites·19 claims
- 1171US8840887B2AntibodiesLIANG WEI-CHING·Filed 2011·Granted Sep 23, 2014·1 cites·20 claims
- 1264US2019010228A1Anti-lrp5 antibodies and methods of useGENENTECH INC·Filed 2018·Application pending·0 cites
- 1364US2010129375A1Methods for inhibiting ocular angiogenesisGENENTECH INC·Filed 2009·Application pending·0 cites
- 1462US10035854B2Method of treating retinopathy with an anti-LRP5 antibodyGENENTECH INC·Filed 2016·Granted Jul 31, 2018·0 cites·30 claims
- 1562US2013324704A1Humanized anti-egfl7 antibodies and methods using sameGENENTECH INC·Filed 2013·Application pending·0 cites
- 1662US2013287779A1Humanized anti-egfl7 antibodies and methods using sameGENENTECH INC·Filed 2013·Application pending·0 cites
- 1762US2009297512A1Compositions and methods for modulating vascular developmentGENENTECH INC·Filed 2009·Application pending·0 cites
- 1862US2005037465A1Novel secreted polypeptide and methods of treatment of bone disordersGENENTECH INC·Filed 2004·Application pending·0 cites
- 1959US9200072B2Anti-LRP5 antibodies and methods of useGENENTECH INC·Filed 2013·Granted Dec 1, 2015·0 cites·35 claims
- 2057US2010203041A1Antibodies to egfl7 and methods for their useGENENTECH INC·Filed 2007·Application pending·0 cites
- 2157US2015093375A1Methods for inhibiting ocular angiogenesisGENENTECH INC·Filed 2014·Application pending·0 cites
- 2256US9284376B2AntibodiesLIANG WEI-CHING·Filed 2011·Granted Mar 15, 2016·0 cites·9 claims
- 2356US2007031437A1Compositions and methods for modulating vascular developmentGENENTECH INC·Filed 2006·Application pending·0 cites
- 2455US2014004038A1Combinatorial therapyGENENTECH INC·Filed 2012·Application pending·0 cites
- 2554US2003044897A1Novel secreted polypeptide and methods of treatment of bone disordersGENENTECH INC·Filed 2001·Application pending·0 cites
- 2654US2013129735A1Antibodies to egfl7 and methods for their useGENENTECH INC·Filed 2013·Application pending·0 cites
- 2753US2004043927A1Compositions and methods for the diagnosis and treatment of disorders involving angiogenesisGENENTECH INC·Filed 2002·Application pending·0 cites
- 2852US2009220504A1Combinatorial therapyCHUNTHARAPAI ANAN·Filed 2007·Application pending·0 cites
- 2951US2012276083A1Methods for inhibiting ocular angiogenesisJUNGE HARALD J·Filed 2011·Application pending·0 cites
- 3050US2003224984A1Compositions and methods for the diagnosis and treatment of disorders involving angiogenesisGENENTECH INC·Filed 2002·Application pending·0 cites
- 3149US9549971B2Methods for inhibiting angiogenesis using EGFL8 antagonistsYE WEILAN·Filed 2009·Granted Jan 24, 2017·0 cites·7 claims
- 3249US2014005113A1Treatment of disorders with altered vascular barrier functionGENENTECH INC·Filed 2013·Application pending·0 cites
- 3347US8790646B2Compositions and methods for modulating vascular developmentFILVAROFF ELLEN·Filed 2010·Granted Jul 29, 2014·0 cites·18 claims
- 3447US2015203581A1Novel anti- alpha5 beta1 antibodies and uses thereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 3540US2008305106A1Novel Gene Disruptions, Composition and Methods Relating TheretoBRENNAN JANE·Filed 2005·Application pending·0 cites
- 3640US2012210450A1Novel gene disruptions, compositions and methods relating theretoDE SAUVAGE FRED·Filed 2011·Application pending·0 cites
- 3738US2015366930A1Treatment of disorders with altered vascular barrier functionGENENTECH INC·Filed 2015·Application pending·0 cites
- 3837US2011097330A1Novel Gene Disruptions, Compostitions and Methods Relating TheretoGENENTECH INC·Filed 2006·Application pending·0 cites
- 3936US2012030776A1Novel gene disruptions, compositions and methods relating theretoCOMBS KATHERIN E·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →